Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study

Cancer Causes and Control

Volumn 23, Issue 9, 2012, Pages 1451-1461

  Jeter, J M ^a,b   Han, J ^c,d   Martinez, M E ^e   Alberts, D S ^a,b   Qureshi, A A ^c   Feskanich, D ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

(Cutaneous) Squamous cell carcinoma; Acetaminophen; Aspirin; Basal cell carcinoma; Melanoma; Non steroidal anti inflammatory medications (NSAIDs); Skin cancer

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER PREVENTION; CANCER RISK; CUTANEOUS MELANOMA; DOSE RESPONSE; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SKIN CANCER; SKIN CARCINOMA; TREATMENT DURATION;

ACETAMINOPHEN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MELANOMA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; UNITED STATES;

EID: 84864875857     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0019-6     Document Type: Article

References (39)

1. Lotze MT, Dallal RM, Kirkwood JM, Flickinger JC (2001) Cutaneous melanoma. In: Devita VT Jr., Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 2012-2013
2. Demierre M-F, Nathanson L (2003) Chemoprevention of melanoma: an unexplored strategy. J Clin Oncol 21:158-165
3. Gruber S, Roush G, Barnhill R (1993) Sensitivity and specificity of self-examination for cutaneous malignant melanoma risk factors. Am J Prevent Med 9:50-53
4. Huang C et al (1997) Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1 luciferase transgenic mice. J Biol Chem 272:26325-26331
5. Denkert C et al (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303-308
6. Zhang J, Bowden G (2008) UVB irradiation regulates Cox-2 mRNA stability through AMPK and HuR in human keratinocytes. Mol Carcinog 47(12):974-983
7. Vogel U et al (2007) Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 617(1-2):138-146
8. Jeter J, Bonner JD, Johnson TH, Gruber SB (2011) Nonsteroidal anti-inflammatory drugs and risk of melanoma. J Skin Cancer 598571. Epub 2011 May 26
9. Colditz G, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5): 894-900
10. Hunter D, Colditz GA, Stampfer MJ, Willett WC, Speizer FE (1990) Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1:13-23
11. Holmes M, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28(9):1467-1472
12. Viswanathan A, Feskanich D, Schernhammer ES, Hankinson SE (2008) Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res 68(7):2507-2513
13. Fairfield K, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE (2002) Aspirin, other NSAIDs, and ovarian cancer risk (United States). Cancer Causes Control 13(6):535-542
14. Schernhammer E, Kang JH, Chan AT, Michaus DS, Skinner HG, Giovannucci E, Colditz GA, Fuchs CS (2004) A prospective study of aspirin use and the risk of pancreatic cancer in women. J Nat Cancer Inst 96(1):22-28
15. Chan A, Manson JE, Feskanich D, Stampfer MJ, Colditz GA, Fuchs CS (2007) Long-term aspirin use and mortality in women. Arch Intern Med 167(6):562-572
16. Chan A, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS (2005) Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colon cancer. JAMA 294(8):914-923
17. Available from http://www.channing.harvard.edu/nhs/
18. Scotto J, Fears TR, Fraumeni JF Jr. (1996) In: Schottenfeld D, Fraumeni JF Jr. (eds) Cancer epidemiology and prevention, 2nd edn. Oxford University Press, New York, pp 355-372
19. Scotto J, Cotton G, Urbach F, Berger D, Fears T (1988) Biologically effective ultraviolet radiation: surface measurements in the United States, 1974 to 1985. Science 239(4841 pt 1):762-764
20. Wolf A, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Corsano KA, Rosner B, Kriska A, Willett WC (1994) Reproducibility and validity of a self-administered activity questionnaire. Int J Epidemiol 23:991-999
21. Willett W, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequence questionnaire. Am J Epidemiol 122(1):51-65
22. Rimm E, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC (1992) Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135(10): 1114-1126
23. Feskanich D, Hunter DJ, Willett WC, Colditz GA (2003) Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women. Br J Cancer 88:1381-1387
24. Cho E, Rosner BA, Feskanich D, Colditz GA (2005) Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 23:2669-2675
25. Subongkot S et al (2003) Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment. Pharmacotherapy 23(1):9-28
26. Harris R, Beebe-Zonk J, Namboodiri K (2001) Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women. Oncol Rep 8(3):655-657
27. Joosse A et al (2009) Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J Invest Dermatol 129(11):2620-2627
28. Curiel-Lewandrowski C, Nijsten T, Gomez ML, Hollestein LM, Atkins MB, Stern RS (2011) Long-term use of nonsteroidal antiinflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol 131(7):1460-1468. doi:10.1038/jid.2011.58
29. Asgari M, Maruti S, White E (2008) A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. J Nat Cancer Inst 100:967-971
30. Ramirez C et al (2005) Use of cyclooxygenase inhibitors and risk of melanoma in high-risk patients. Dermatol Surg 31:748-753
31. Butler G et al (2005) Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J Am Acad Dermatol 53(6):966-972
32. Asgari M, Chren M-M, Warton EM, Friedman GD, White E (2010) Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol 146(4):388-395
33. Clouser M et al (2009) Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAPAK trial. Pharmacoepidemiol Drug Saf 18(4):276-283
34. Glau M et al (2006) Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 119(3):682-686
35. Tang J et al (2010) Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1 ± humans and mice. Cancer Prev Res 3(1):25-34
36. Elmets C, Viner JL, Pentland AP, Cantrell W, Lin H-Y, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB (2010) Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Nat Cancer Inst 102:1-10
37. Vad N et al (2009) Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice. Int J Oncol 35(1): 193-204
38. Vad N et al (2009) Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines. J Pharm Sci 98(4):1409-1425
39. Scherer D, Kumar R (2010) Genetics of pigmentation in skin cancer-a review. Mutat Res 705(2):141-153